High Vista Strategies LLC Biocryst Pharmaceuticals Inc Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $478,326 - $605,467	68,725 New	68,725 $483,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $278,781 - $382,645	25,837 New	25,837 $326,000
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $217,640 - $270,327	-15,316 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $69,897 - $129,077	-9,484 Reduced 38.24%	15,316 $156,000
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $85,064 - $137,144	24,800 New	24,800 $85,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.